Analysis of Influencing Factors of Unplanned Readmission in Patients With Acute Coronary Syndrome Within 30 Days After PCI
DOI:
https://doi.org/10.1532/hsf.4411Keywords:
Acute coronary syndrome, Percutaneous coronary intervention, Unplanned readmission, influence factorAbstract
Objective: The purpose of this study is to identify the influencing factors of unplanned readmission in patients with the acute coronary syndrome (ACS) within 30 days after percutaneous coronary intervention (PCI).
Methods: From November 1, 2018, to October 31, 2019, the clinical data of 1277 patients with acute coronary syndrome and percutaneous coronary intervention retrospectively were collected. After screening by exclusion and rejection criteria, a total of 936 patients finally entered the study. Patients were divided into the readmission group (57 cases) and the non-readmission group (879 cases), according to whether unplanned readmission occurred within 30 days after PCI. To analyze the influence of patients' age, past disease history, medication history, laboratory data, vascular diseases, and other factors on readmission and the clinical characteristics of readmission patients.
Results: Fifty-seven patients had unplanned readmission within 30 days, and the readmission rate was 6.09%. The clinical features of readmission patients are older age, longer hospitalization days, more emergency percutaneous coronary intervention, more patients with diabetes history, and more patients diagnosed with ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction. Logistic regression analysis revealed that smoking index, number of diseased vessels, ACEF score, diabetes, and PCI status were the influencing factors of unplanned readmission of ACS patients within 30 days after PCI.
Conclusion: Smoking index, number of diseased vessels, ACEF score, diabetes, and PCI status are the influencing factors of unplanned readmission within 30 days after percutaneous coronary intervention for patients with acute coronary syndrome.
References
arywani SB, Petzold M. 2016. Octogenarians died mainly of cardiovascular diseases five years after acute coronary syndrome[J]. Scandinavian Cardiovascular Journal. 50(5-6): 300-304.
Chow CK, Jolly S, Rao-Melacini P, et al. 2010. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes[J]. Circulation. 121(6): 750-758.
Critchley JA, Capewell S. 2003. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review[J]. Jama. 290(1): 86-97.
Epstein AJ, Daniel P, Feifei Y, et al. 2011. Coronary revascularization trends in the United States, 2001-2008[J]. Jama. 305(17): 1769.
Fanari Z, Elliott D, Russo CA, et al. 2017. Predicting readmission risk following percutaneous coronary intervention at the time of admission[J]. Cardiovascular Revascularization Medicine. 18(2): 100-104.
Hannan EL, Zhong Y, Krumholz H, et al. 2011. 30-day readmission for patients undergoing percutaneous coronary interventions in New York state[J]. JACC Cardiovascular Interventions. 4(12): 1335-1342.
Kwok CS, Hulme W, Olier I, et al. 2016. Review of early hospitalisation after percutaneous coronary intervention[J]. International Journal of Cardiology. 227(2017): 370-377.
Kwok CS, Rao SV, Potts JE, et al. 2018. Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database[J]. JACC Cardiovascular Interventions. 11(7): 665-674.
Lam L, Ahn HJ, Okajima K, et al. 2019. Gender Differences in the Rate of 30-Day Readmissions after Percutaneous Coronary Intervention for Acute Coronary Syndrome[J]. Womens Health Issues. 29(1): 17-22.
Mapanga RF, Joseph D, Symington B, et al. 2014. Detrimental effects of acute hyperglycaemia on the rat heart[J]. Acta Physiologica. 210(3): 546-564.
Moretti C, Meynet I, D'ascenzo F, et al. 2015. Sixty-day readmission rate after percutaneous coronary intervention: predictors and impact on long-term outcomes[J]. European Heart Journal Quality of Care and Clinical Outcomes. 1(2): 79-84.
Ranucci M, Castelvecchio S, Menicanti L, et al. 2009. Risk of assessing mortality risk in elective cardiac operations: age, creatinine, ejection fraction, and the law of parsimony[J]. Circulation, 2009, 119(24): 3053-3061.
Shengshou H, Runlin G, Lisheng L, et al. 2019. Summary of the 2018 Report on Cardiovascular Diseases in China [J]. Chinese Circulation Journal. 34(3): 209-220.
Spitzer E, Frei M, Zaugg S, et al. 2017. Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized Trial[J]. J Am Heart Assoc. 6(8): 1-18.
Tripathi A, Abbott J, Fonarow G, et al. 2017. Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States A National Readmission Database Analysis[J]. Circulation Cardiovascular Interventions. 69(11): 1093.
Ya W, Jifang C, Chongbin L, et al. 2020. Research progress on early readmission of patients after percutaneous coronary intervention [J]. Chinese Journal of Nursing. 55(10): 1598-1600.
Ya W, Wen-Jing S, Ze-Sheng J, et al. 2020. Serum albumin and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention[J]. Reviews in cardiovascular medicine. 21(1): 139-145.
Yost GW, Puher SL, Graham J, et al. 2013. Readmission in the 30 Days After Percutaneous Coronary Intervention[J]. Jacc Cardiovascular Interventions. 6(3): 237-244.
